News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
FDA
Spectral Diagnostics’s West Nile Virus Test Gets FDA Nod
December 12, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
TORONTO, Dec 12 (Reuters) - Spectral Diagnostics Inc. (SDI.TO: Quote, Profile , Research) said on Tuesday its West Nile Virus test received marketing approval from the U.S. Food and Drug Administration.
>>>
Discuss This Story
Twitter
LinkedIn
Facebook
Email
Print
FDA
Approvals
MORE ON THIS TOPIC
Alzheimer’s disease
Roche, Lilly Win First FDA Nod for Alzheimer’s Blood Test for Primary Care Use
October 14, 2025
·
2 min read
·
Tristan Manalac
Rare diseases
Nearly Three Quarters of FDA Breakthrough Designated Drugs Win Approval: Report
October 9, 2025
·
3 min read
·
Dan Samorodnitsky
Approvals
Boehringer Ingelheim Breaks Decade-Long Approval Drought in Idiopathic Pulmonary Fibrosis
October 8, 2025
·
2 min read
·
Tristan Manalac
Regulatory
Marks Finds His Next Role as Lilly Snags Another Former FDA Regulator
October 7, 2025
·
1 min read
·
Heather McKenzie
